Lactide and glycolide (co)polymerization catalytic system

Details for Australian Patent Application No. 2004207648 (hide)

Owner Centre National de la Recherche Scientifique (C.N.R.S.) IPSEN Pharma S.A.S.

Inventors Lacombe, Frederic; Dumitrescu, Anca; Cazaux, Jean-Bernard; Vranicar, Lidija; Bourissou, Didier; Cherif-Cheikh, Roland; Martin-Vaca, Blanca

Agent Watermark

Pub. Number AU-B-2004207648

PCT Pub. Number WO2004/067602

Priority 03290134.0 21.01.03 EP

Filing date 19 January 2004

Wipo publication date 12 August 2004

Acceptance publication date 12 November 2009

International Classifications

C08G 63/82 (2006.01) Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule

C08G 63/87 (2006.01) Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule

Event Publications

11 August 2005 PCT application entered the National Phase

  PCT publication WO2004/067602 Priority application(s): WO2004/067602

12 March 2009 Alteration of Name

  The name of the applicant has been altered to Centre National de la Recherche Scientifique (C.N.R.S.); IPSEN Pharma S.A.S

12 November 2009 Application Accepted

  Published as AU-B-2004207648

11 February 2010 Amendment Made

  The nature of the amendment is: Amend the co-applicant name from IPSEN Pharma S.A.S. to IPSEN PHARMA S.A.S.

11 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004207657-Aryl alkyl carbamate derivatives production and use thereof in therapy

2004207647-Conjugates obtained by reductive amination of serotype 5 pneumococcus capsular polysaccharide